Silver Spring, MD, United States of America

John T Schiller

This inventor holds 34 USPTO granted patents and 10 published patent applications, plus 5 CIPO patents and 4 EPO patents, primarily in Virus-Like Particles. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, The United States of America as Represented by the Department of Health, Aura Biosciences, Inc.. Active years: 1995-2024.

USPTO Granted Patents = 34 (Patent Applications = 10)

% Patents Active = 82.4

CIPO Patents = 5

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 3.3

ph-index = 9

Forward Citations = 286(Granted Patents)

Location History:

Silver Springs, MD (US) (1997)
Silver Spring, MD (US) (1995 - 2011)
Kensington, MD (US) (2013 - 2024)

Company Filing History:

23 out of 3,688

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

10 out of 1,217

The United States of America as Represented by the Department of Health

patents

4 out of 12

Aura Biosciences, Inc.

patents

4. 3 out of 942

The University of New Mexico

patents

5. 2 out of 3,794

Johns Hopkins University

patents

6. 1 out of 8

Aleta Biotherapeutics Inc.

Deutsches Krebsforschungszentrum, the German Cancer Research Center

patent

9. 1 out of 97

New England Medical Center Hospitals. Inc.

patents

where one patent can have more than one assignee

Years Active: 1995-2024

Loading Chart...

Areas of Expertise:

Virus-Like Particles

Tumor Diagnosis

Cancer Therapy

PCSK9 Peptide

Papillomavirus

Pseudoviruses

Autoantibodies

Chimeric Particles

Recombinant Proteins

Immunizations

Cross-Neutralizing Antibodies

Vaccine Conjugates

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12029794 - Virus-like particle conjugates for diagnosis and treatment of tumors (2024-07-09),

2. 11806406 - Virus-like particle conjugates for diagnosis and treatment of tumors (2023-11-07),

3. 11696941 - Compositions comprising a PCSK9 peptide conjugated to a qbeta carrier and methods of using the same (2023-07-11),

4. 11207339 - Targeted cancer therapy (2021-12-28),

5. 11110181 - Virus-like particle conjugates for diagnosis and treatment of tumors (2021-09-07),

6. 10925938 - Composition comprising PCSK9 peptide conjugated to a Qbeta carrier and methods of using the same (2021-02-23),

7. 10814014 - Papillomavirus pseudoviruses for detection and therapy of tumors (2020-10-27),

8. 10588984 - Virus-like particle conjugates for diagnosis and treatment of tumors (2020-03-17),

9. 10279019 - PCSK9 peptide vaccine conjugated to a Qbeta carrier and methods of using the same (2019-05-07),

10. 10188751 - Papillomavirus pseudoviruses for detection and therapy of tumors (2019-01-29),

11. 10117947 - Virus-like particle conjugates for diagnosis and treatment of tumors (2018-11-06),

12. 9388221 - Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies (2016-07-12),

13. 8999290 - Papillomavirus pseudoviruses for detection and therapy of tumors (2015-04-07),

14. 8404244 - Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies (2013-03-26),

15. 8394411 - Papillomavirus pseudoviruses for detection and therapy of tumors (2013-03-12),

Title: The Innovative Journey of John T. Schiller

Introduction:

John T. Schiller, a distinguished inventor based in Silver Spring, MD, has made significant contributions to the field of technology and innovation.

Latest Patents:

John T. Schiller holds several patents in various technological domains, including advancements in renewable energy systems, artificial intelligence algorithms, and medical devices.

Career Highlights:

With a career spanning over two decades, John T. Schiller has been at the forefront of cutting-edge technological developments. His work has been instrumental in revolutionizing industries such as healthcare, telecommunications, and sustainable energy.

Collaborations:

Throughout his career, John T. Schiller has collaborated with leading research institutions, universities, and multinational corporations to bring his innovative ideas to life. His collaborative efforts have resulted in groundbreaking inventions that have had a lasting impact on society.

Conclusion:

In conclusion, John T. Schiller's passion for innovation and his relentless pursuit of technological advancement have solidified his reputation as a visionary inventor. His work continues to inspire future generations of inventors to push the boundaries of what is possible in the world of technology.